-
Concern About AMD's Dependence On Crypto Data Mining?
Tuesday, August 8, 2017 - 3:06pm | 319Read More...The fact that Advanced Micro Devices, Inc. (NASDAQ: AMD)’s quarterly beat was driven almost entirely by the sale of the data-mining graphics processing units for the Ethereum cryptocurrency should be a cause for concern among investors, Barclay analysts said Tuesday. “This does not mean...
-
How The Law Of Large Numbers Makes It Tough For Starbucks To Meet Expectations
Friday, November 4, 2016 - 10:42am | 295Read More...Starbucks Corporation (NASDAQ: SBUX) announced its Q4 EPS ahead of expectations, while its F17 guide reflected acceleration in the back half. There seems to be “too much attention” on the company’s US comp growth, Barclay’s Jeffrey A. Bernstein said in a report. He...
-
FitBit Had 'A Very Healthy Holiday'
Tuesday, December 29, 2015 - 8:54am | 360Read More...Fitbit Inc (NYSE: FIT) shares are down 14 percent in the last six months, even after hitting a high of $51.64 on August 5. Barclay’s Matthew McClintock maintained an Overweight rating for the company, with a price target of $49. Fitbit's strength during Black Friday continued...
-
Why Fitbit Is On The 'SmartTrack' To Growth
Wednesday, December 9, 2015 - 9:02am | 333Read More...After trading above $40 on November 2, Fitbit Inc (NYSE: FIT) shares have slumped 15 percent in the past one month Barclay’s Matthew McClintock maintained an Overweight rating on the company, with a price target of $49. A meeting with management indicated several areas of growth for...
-
Analysts: Splunk's Shift To Term Licenses Is Revenue Headwind
Friday, May 29, 2015 - 1:22pm | 345Read More...Splunk Inc (NASDAQ: SPLK) fell sharply Friday despite beating first quarter estimates and multiple love notes from Wall Street analysts. The analytics software company traded down more than 4 percent recently at $67.76. The sell-off was sparked by concern that Splunk's billings growth...
-
Barclays Analyst Sees iPhone Content Gains For Avago Technologies
Tuesday, May 12, 2015 - 4:28pm | 241Read More...Avago Technologies Ltd (NASDAQ: AVGO) will be among companies benefiting from upcoming versions of the iPhone, an analyst said Tuesday. Barclay's Blayne Curtis reinstated coverage of Avago with an Overweight rating and called it a "top idea" among radio frequency...
-
Godaddy Gains On Raft Of Favorable Coverage
Monday, May 11, 2015 - 12:58pm | 272Read More...Godaddy Inc (NYSE: GDDY) shares gained Monday as a raft of analysts launched mostly favorable coverage on the Web hosting company. The Scottsdale, Arizona-based company is off more than 1 percent since going public last month, but traded Monday at $25.90, up 4 percent. With roughly three-quarters...
-
Barclays Analyst Sees Sick Shifting From Hospitals To Outpatient Clinics
Thursday, January 8, 2015 - 5:30pm | 235Read More...A shift to outpatient facilities from hospitals will continue to accelerate under healthcare reform and favor companies well-positioned for the switch, an analyst said Thursday. "We're seeing a clear movement to outpatient services," Barclay's Joshua Raskin said, calling 2014...
-
Barclays Analyst Sees Broad Strength In Just-Ended Retail Season
Wednesday, January 7, 2015 - 6:15pm | 359Read More...Broad strength in the just-ended holiday shopping season got tempered by weakness in specialty apparel, while heavy promotions pressured retailers' margins, an analyst said Wednesday. Gap Inc (NYSE: GPS) and L Brands Inc (NYSE: LB) are slated to post December sales on Thursday. A...
-
UPDATE: Barclays Initiates Coverage On United Therapeutics
Tuesday, January 6, 2015 - 2:03pm | 246Read More...United Therapeutics Corporation (NASDAQ: UTHR) is facing patent expirations, increasing competition and an uncertain pipeline of prospective new products, an analyst said Tuesday. Barclay's Geoffrey Meacham launched coverage on the drug maker with an Equal-Weight rating and $135 target....
-
Barclays Analyst Sees Biotech FY15 EPS Growth Outstripping Market
Tuesday, January 6, 2015 - 1:21pm | 427Read More...The biotech sector's expected 2015 earnings growth of 19 percent will far outpace the broader market while drug reimbursement rates will remain healthy, an analyst said Tuesday. Barclay's Geoffrey Meacham launched coverage on 10 large- and mid-cap companies in the sector and said the...
-
Barclays Adjusts Ratings For Major Refineries
Friday, July 25, 2014 - 2:43pm | 234Read More...In a report released Friday, Barclay analyst Paul Cheng released coverage on major oil companies such as Petroleo Brasileiro Petrobras SA (NYSE: PBR), Exxon Mobil (NYSE: XOM), ConocoPhillips (NYSE: COP), Chevron (NYSE: CVX) and Suncor Energy (NYSE: SU). Petroleo Brasileiro Petrobras SA -...
-
Barclays Says Charter Communication's SpinCo Investment Still Not Priced In
Monday, July 7, 2014 - 12:37pm | 213Read More...Despite a big run-up in share price, Charter Communications (NASDAQ: CHTR) may not be fully valued, according to one analyst. Barclay's Kannan Venkateshwar said Charter's 33 percent stake in the soon-to-be-created SpinCo hasn't yet been priced in by the market. SpinCo, with an...
